Live Breaking News & Updates on Vaccines Clinical Trial Insights

Stay updated with breaking news from Vaccines clinical trial insights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global Influenza Vaccines Market Report 2021-2027 Featuring Emerging Players - Moderna, Novavax, Daiichi Sankyo, & Versatope Therapeutics


Share this article
Share this article
ResearchAndMarkets.com s offering.
The number of people being vaccinated with influenza vaccines worldwide will reach 500 million by the year-end of 2027.
The Report Analyses the Market Based on Countries and Presents the Forecast in Terms of Value and Volume for the Next Six Years.
Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccines, the introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most of the countries.
Long-term Growth Projection:
The global influenza vaccines market size is set to surpass US$ 6.5 Billion by the year-end of 2021 ....

United States , United Kingdom , Sanofi Pasteur , Daiichi Sankyo , Laura Wood , Hualan Biological Engineering Inc , Biondvax Pharmaceuticals Ltd , Company Country , Key Companies Analysis , Platform Technology , Moderna Inc , National Persons Being , Clinical Development , Versatope Therapeutics Inc , Shanghai Institute Of Biological Products Co Ltd , Office Hours Call , National Influenza Vaccines Market , Gamma Vaccines Pty Ltd , E St Office Hours Call , Influenza Vaccines Market , Report Analyses , Market Based , Next Six , Growth Projection , Market Size , Global Influenza Vaccines Market ,